USD 0.01
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 144.83 Thousand USD | -62.34% |
2023 | 384.59 Thousand USD | -29.22% |
2022 | 543.36 Thousand USD | 1372.82% |
2021 | 36.89 Thousand USD | 0.0% |
2020 | - USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 8723.00 USD | -45.27% |
2024 Q4 | 99.18 Thousand USD | 1037.07% |
2024 Q2 | 15.93 Thousand USD | -24.04% |
2024 Q1 | 20.98 Thousand USD | -55.45% |
2024 FY | 144.83 Thousand USD | -62.34% |
2023 Q2 | 9208.00 USD | -96.67% |
2023 FY | 384.59 Thousand USD | -29.22% |
2023 Q4 | 47.09 Thousand USD | -9.01% |
2023 Q3 | 51.76 Thousand USD | 462.16% |
2023 Q1 | 276.52 Thousand USD | -2.73% |
2022 FY | 543.36 Thousand USD | 1372.82% |
2022 Q1 | 101.67 Thousand USD | 328.46% |
2022 Q3 | 16.02 Thousand USD | -91.08% |
2022 Q2 | 179.6 Thousand USD | 76.65% |
2022 Q4 | 284.28 Thousand USD | 1674.58% |
2021 Q2 | 30.00 USD | -99.65% |
2021 FY | 36.89 Thousand USD | 0.0% |
2021 Q4 | 23.72 Thousand USD | 421.06% |
2021 Q3 | 4554.00 USD | 15080.0% |
2021 Q1 | 8580.00 USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
China Medicine Corporation | 6.71 Million USD | 97.844% |
Exlites Holdings International, Inc. | 34.23 Thousand USD | -323.08% |
Itonis, Inc. | 40.11 Thousand USD | -261.053% |
One Step Vending Corp. | 26.55 Thousand USD | -445.469% |
MediPal Holdings Corporation | 1.22 Billion USD | 99.988% |
PD-Rx Pharmaceuticals, Inc. | 6.9 Million USD | 97.901% |
Pharmagen, Inc. | 6038.12 USD | -2298.644% |
Suzuken Co., Ltd. | 993.51 Million USD | 99.985% |